# Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

> **NCT00914914** · PHASE1 · COMPLETED · sponsor: **Dr. Tapas K. Das Gupta** · enrollment: 15 (actual)

## Conditions studied

- Refractory Solid Tumors

## Interventions

- **DRUG:** p28

## Key facts

- **NCT ID:** NCT00914914
- **Lead sponsor:** Dr. Tapas K. Das Gupta
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-04
- **Final completion:** 2011-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914914, "Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00914914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*